Furthermore, in vitro studies have further shown that knockdown of TRIM66 reduces the proliferation of NSCLC, colorectal, HCC and prostate cancers, indicating an oncogenic role [42,43,46,50]. Here, TRIM66 is linked to non-small cell lung carcinoma.